Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prospects for proton-beam radiotherapy

A E Nahum1, D P Dearnaley, G G Steel

  • 1Joint Department of Physics, Royal Marsden Hospital, Sutton, Surrey, U.K.

European Journal of Cancer (Oxford, England : 1990)
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992-2003.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Seven or less Fractions is Not the Standard of Care for Intermediate-Risk Prostate Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2019
Same author

Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Validation of T2- and diffusion-weighted magnetic resonance imaging for mapping intra-prostatic tumour prior to focal boost dose-escalation using intensity-modulated radiotherapy (IMRT).

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2019
Same author

Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity.

Clinical oncology (Royal College of Radiologists (Great Britain))·2019
Same author

Dosimetry and Gastrointestinal Toxicity Relationships in a Phase II Trial of Pelvic Lymph Node Radiotherapy in Advanced Localised Prostate Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2019

Proton beam therapy is currently used in 15 global centers for radiation therapy, with more planned. This high-precision radiotherapy shows promise for improved treatment of specific tumors in certain locations.

Area of Science:

  • Medical Physics
  • Radiation Oncology

Background:

  • Proton beam therapy is an advanced form of radiation therapy.
  • Currently, 15 centers worldwide utilize proton beams, with additional facilities under development.

Purpose of the Study:

  • To evaluate the current status and potential benefits of proton beam therapy in clinical practice.
  • To assess the predicted dose distributions for various tumor sites compared to conventional photon radiotherapy.

Main Methods:

  • Review of current clinical applications and planned expansions of proton beam therapy centers.
  • Calculation and comparison of dose distributions for proton and photon radiotherapy in specific tumor sites (brain, lung, head and neck, pelvis).

Main Results:

  • Positive clinical outcomes have been reported for uveal melanomas and skull base sarcomas.

Related Experiment Videos

  • Calculated dose distributions suggest improved outcomes for brain, lung, head and neck, and pelvic tumors compared to photon therapy.

    • Conclusions:

    • Proton beam therapy is an established and expanding treatment modality.
    • Proton therapy offers the potential for high-precision radiotherapy, leading to improved treatment efficacy for specific oncological conditions.